Table of Contents
ISRN Pharmacology
Volume 2013 (2013), Article ID 768792, 5 pages
http://dx.doi.org/10.1155/2013/768792
Research Article

Drug Utilization Study in Ophthalmology Outpatients at a Tertiary Care Teaching Hospital

Department of Pharmacology, MGM Medical College & Hospital, Sector 18, Kamothe, Navi Mumbai, Maharashtra 410 209, India

Received 10 September 2013; Accepted 30 September 2013

Academic Editors: K. Cimanga and T. B. Vree

Copyright © 2013 Pradeep R. Jadhav et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization (WHO) and International Network for Rational Use of Drugs, How to Investigate Drug Use in Health Facilities: Selected Drug Use indicators, WHO/DAP/93.1, WHO, Geneva, Switzerland, 1993.
  2. World Health Organization (WHO) International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services, Introduction to Drug Utilization Research, WHO, Oslo, Norway, 2003.
  3. World Health Organization, Introduction to Drug Utilization Research, WHO, Oslo, Norway, 2003, http://apps.who.int/medicinedocs/en/d/Js4876e/.
  4. D. Lee and U. Bergman, “Studies of drug utilization,” in Pharmacoepidemiology, L. B. Storm, Ed., pp. 401–417, John Wiley & Sons, Chichester, UK, 2005. View at Google Scholar
  5. N. Y. Mirza, S. Desai, and B. Ganguly, “Prescribing pattern in a pediatric out-patient department in Gujarat,” Bangladesh Journal of Pharmacology, vol. 4, no. 1, pp. 39–42, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. H. V. Hogerzeil, “Promoting rational prescribing: an international perspective,” British Journal of Clinical Pharmacology, vol. 39, no. 1, pp. 1–6, 1995. View at Google Scholar · View at Scopus
  7. B. Dineshkumar, T. C. Raghuram, G. Radhaiah, and K. Krishnaswamy, “Profile of drug use in urban and rural India,” PharmacoEconomics, vol. 7, no. 4, pp. 332–346, 1995. View at Google Scholar · View at Scopus
  8. R. Likic, I. Francetic, M. Bilusic et al., “Benefits of optimisation in antibiotic use,” Collegium Antropologicum, vol. 31, no. 1, pp. 241–246, 2007. View at Google Scholar
  9. A. Duggirala, J. Joseph, S. Sharma, R. Nutheti, P. Garg, and T. Das, “Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison,” Indian Journal of Ophthalmology, vol. 55, no. 1, pp. 15–19, 2007. View at Google Scholar · View at Scopus
  10. A. Leonardi, “Emerging drugs for ocular allergy,” Expert Opinion on Emerging Drugs, vol. 10, no. 3, pp. 505–520, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. N. A. Afshari, J. J. K. Ma, S. M. Duncan et al., “Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis,” Journal of Ocular Pharmacology and Therapeutics, vol. 24, no. 2, pp. 217–223, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. P. A. Asbell, K. A. Colby, S. Deng et al., “Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates,” American Journal of Ophthalmology, vol. 145, no. 6, pp. 951–958, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. R. P. Kowalski, L. M. Karenchak, and E. G. Romanowski, “Infectious disease: changing antibiotic susceptibility,” Ophthalmology Clinics of North America, vol. 16, no. 1, pp. 1–9, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. A. K. Sood, A. Gupta, and T. Dabral, “Indiscriminate use of topical antibiotics: a menace,” Indian Journal of Ophthalmology, vol. 47, no. 2, pp. 121–124, 1999. View at Google Scholar · View at Scopus
  15. B. I. Gaynes and R. Fiscella, “Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review,” Drug Safety, vol. 25, no. 4, pp. 233–250, 2002. View at Google Scholar · View at Scopus
  16. K. Krishnaswamy, B. Dinesh Kumar, and G. Radhaiah, “A drug survey—precepts and practices,” European Journal of Clinical Pharmacology, vol. 29, no. 3, pp. 363–370, 1985. View at Google Scholar · View at Scopus
  17. The Government of India, Ministry of Health & Family Welfare (MOHFW), “National Formulary of India,” 2011, http://www.cdsco.nic.in/NFI_2011.pdf.
  18. Central Drugs Standard Control Organization, “National Formulary of India,” 2011, http://cdsco.nic.in/National%20List%20of%20Essential%20Medicine-%20final%20copy.pdf.
  19. N. R. Biswas, R. S. Biswas, P. S. Pal et al., “Patterns of prescriptions and drug use in two tertiary hospitals in Delhi,” Indian Journal of Physiology and Pharmacology, vol. 44, no. 1, pp. 109–112, 2000. View at Google Scholar · View at Scopus
  20. N. R. Biswas, S. Jindal, M. Mairaj Siddiquei, and R. Maini, “Patterns of prescription and drug use in ophthalmology in a tertiary hospital in Delhi,” British Journal of Clinical Pharmacology, vol. 51, no. 3, pp. 267–269, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Singh, N. R. Biswas, S. K. Jain, and G. K. Das, “Prescribing trends in ophthalmology,” The Indian Journal of Clinical Pharmacology and Therapeutics, vol. 18, no. 4, p. 79, 1998. View at Google Scholar
  22. Y. Maniyar, P. Bhixavatimath, and V. Akkone, “A drug utilization study in the ophthalmology department of a medical college, Karnataka, India,” Journal of Clinical and Diagnostic Research, vol. 5, no. 1, pp. 82–84, 2011. View at Google Scholar · View at Scopus
  23. M. Nehru, K. Kohli, B. Kapoor, P. Sadhotra, V. Chopra, and R. Sharma, “Drug utilization study in outpatient ophthalmology department of Government Medical College Jammu,” JK Science, vol. 7, no. 3, pp. 149–151, 2005. View at Google Scholar · View at Scopus
  24. V. P. Jain, B. Shrivastava, and M. Agarwal, “Drug utilization pattern of drugs used along ophthalmic antiallergics formulations used in patients diagnosed with seasonal and perennial allergic conjunctivitis,” Asian Journal of Pharmaceutical Sciences and Research, vol. 1, no. 5, pp. 15–20, 2011. View at Google Scholar
  25. R. E. Weir, F. H. Zaidi, D. G. Charteris, C. Bunce, M. Soltani, and A. M. Lovering, “Variability in the content of Indian generic ciprofloxacin eye drops,” British Journal of Ophthalmology, vol. 89, no. 9, pp. 1094–1096, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Mohanty and S. Mohapatra, “Drug utiliation pattern of topical ocular antimicrobials in a tertiary care hospital,” Indian Journal of Pharmacology, vol. 35, no. 6, p. 399, 2003. View at Google Scholar · View at Scopus
  27. F. S. Mah, “Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections,” Current Opinion in Ophthalmology, vol. 15, no. 4, pp. 316–320, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. L. J. Cervantes and F. S. Mah, “Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis,” Clinical Ophthalmology, vol. 5, no. 1, pp. 495–502, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Nye, S. Rudner, and L. Bielory L, “Emerging therapies in allergic conjunctivitis and dry eye syndrome,” Expert Opinion on Pharmacotherapy, vol. 14, no. 11, pp. 1449–1465, 2013. View at Google Scholar
  30. M. C. Sanchez, B. F. Parra, V. Matheu et al., “Allergic conjunctivitis,” Journal of Investigational Allergology and Clinical Immunology, vol. 21, no. 2, pp. 1–19, 2011. View at Google Scholar